跳至主要内容
临床试验/JPRN-UMIN000035382
JPRN-UMIN000035382
尚未招募
未知

Compare the efficacy of diagnostic treatment with P-CAB and PPI before to do endoscopy for GERD patients. - Compare the efficacy of treatment with P-CAB and PPI in patients with GERD.

Kitasato University0 个研究点目标入组 100 人2019年3月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Gastroesophageal reflux disease
发起方
Kitasato University
入组人数
100
状态
尚未招募
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2019年3月1日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 未提供

排除标准

  • 1\.Patients with a history of hypersensitivity to components of Vonoprazan and Esomeprazole. 2\.Patients taking PPI including Vonoprazan and Esomeprazole. 3\.Patients taking Atazanavir sulfate and Rilpivirine hydrochloride. 4\.Patients who are diagnosed Zollinger\-Ellison syndrome and Pernicious anemia. 5\.Patients who have complicated other severe diseases and whose clinical trials can not be safety performed or whose effect judgment is difficult. 6\.Patients with malignant tumor complications. 7\.Patients with a history of surgery of the upper gastrointestinal tract including the stomach and esophagus. 8\.Patients who may be pregnant or pregnant. 9\.Patients who judged by physician inappropriate to participate in clinical trials.

结局指标

主要结局

未指定

相似试验